This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Insiders Love Right Now

Opko Health

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

A pharmaceutical and diagnostics player whose insiders are doing some active buying is Opko Health (OPK), which is focused on developing a range of solutions, including molecular diagnostics tests, pharmaceuticals and vaccines. This stock has done absolutely nothing so far in 2012, with shares virtually flat on the year.

Opko Health has a market cap of $1.39 billion and an enterprise value of $1.33 billion. This stock trades at a lofty valuation, with a price-to-sales of 32.71 and a price-to-book of 13.65. This is a cash-rich company, since the total cash position on its balance sheet is $87.42 million and its total debt is $12.55 million.

The CEO and chairman of the board just bought 500,000 shares, or about $2.36 million worth of stock, at $4.72 per share.

From a technical perspective, OPK is currently trading above its 200-day moving average and right below its 50-day moving average, which is neutral trendwise. For the past month and change, this stock has found some buying support at around $4.70 to $4.66 a share, and it has run into selling resistance near $5.50 and above.

If you're a bullish on OPK, then I would look for long-biased trades once this stock takes out its 50-day moving average of $5.03 with high volume. Look for volume on that move that's near or well above its three-month average action of 1,414,680 shares. If we get that action soon, I would then only add to any long positions once $5.60 to $5.85 a share are taken out with big volume. Otherwise, I would simply lock in profits near those levels if the sellers continue to defend their positions.

Opko shows up in Jana Partners' portfolio as of the most recently reported period, with a 2 million-share position.

4 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,069.49 -1.73 -0.01%
S&P 500 1,976.91 -0.89 -0.04%
NASDAQ 4,498.6730 -7.1790 -0.16%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs